Andreas H. Scheel
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 28
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 7
- Lung Cancer Research Studies 4
- Cancer-related Molecular Pathways 4
-
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Reinhard Buettner (14 shared papers)Jürgen Wolf (7 shared papers)Anne M. Schultheis (6 shared papers)Matthias Dobbelstein (5 shared papers)Josef Rüschoff (10 shared papers)Julie George (6 shared papers)Thomas Zander (5 shared papers)Hans‐Ulrich Schildhaus (11 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Diagnostic Pathology (3 papers)Journal of Thoracic Oncology (3 papers)Scientific Reports (2 papers)Modern Pathology (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Andreas H. Scheel
55 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 85
- Oncology 888
- Cancer Research 218
- Pulmonary and Respiratory Medicine 420
- Immunology 181
- Molecular Biology 418
Countries citing papers authored by Andreas H. Scheel
This map shows the geographic impact of Andreas H. Scheel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas H. Scheel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas H. Scheel more than expected).
Fields of papers citing papers by Andreas H. Scheel
This network shows the impact of papers produced by Andreas H. Scheel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas H. Scheel. The network helps show where Andreas H. Scheel may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas H. Scheel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 268 | |
| 2 | 2015 | 192 | |
| 3 | 2016 | 94 | |
| 4 | 2010 | 93 | |
| 5 | 2016 | 90 | |
| 6 | 2014 | 78 | |
| 7 | 2010 | 66 | |
| 8 | 2012 | 58 | |
| 9 | 2021 | 57 | |
| 10 | 2021 | 48 | |
| 11 | 2014 | 44 | |
| 12 | 2018 | 43 | |
| 13 | 2015 | 43 | |
| 14 | 2019 | 32 | |
| 15 | 2016 | 31 | |
| 16 | 2014 | 31 | |
| 17 | 2017 | 30 | |
| 18 | 2012 | 27 | |
| 19 | 2009 | 27 | |
| 20 | 2013 | 26 |
About Andreas H. Scheel
Andreas H. Scheel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (8 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Lung Cancer Research Studies (4 papers), Cancer-related Molecular Pathways (4 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Oncology (888 citations), Cancer Research (218 citations), Pulmonary and Respiratory Medicine (420 citations), Immunology (181 citations) and Molecular Biology (418 citations). Andreas H. Scheel has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Reinhard Buettner, Jürgen Wolf, Anne M. Schultheis, Matthias Dobbelstein, Josef Rüschoff, Julie George, Thomas Zander, Hans‐Ulrich Schildhaus, Rieke Fischer and Roman K. Thomas. Their work appears in journals such as Journal of Clinical Oncology, Diagnostic Pathology, Journal of Thoracic Oncology, Scientific Reports and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.